Abstract:Background: Angiotensin II (Ang II) can induce cardiac hypertrophy and platelet-derived growth factor(PDGF) also stimulates cardiac hypertrophy. Is AngII responsible for the pathogenesis of cardiac hypertrophy by inducing PDGF receptor expression? Objective: To investigate the effect of mitogen activated protein kinase (MAPK) on the role of cardiac hypertrophy induced by Ang II in cardiac myocytes so as to provide theoretical basis for clinical prevention and cure of cardiac hypertrophy. Design: Controlled experimental study taking cardiac myocytes of cultured neonatal rats as subjects. Setting: Department of pathophysiology in a university. Materials: The experiment was completed in the Department of Pathophysiology, Medical College of Peking University. A total of 80 Wistar rats of either gender, aged 1-3 days, were provided by the Animal Center of Medical College, Peking University. Their hearts were removed for myocyte culture in the Cell Culture Laboratory. Interventions: The cultured neonatal rat cardiac myocytes treated with 10-7mol/L Ang II were Ang II group, and those preincubated with 10-5mol/L PD98059 (an antagonist of MAPK) for 30 minutes and then treated with Ang II were PD98059 group. Cardiac myocytes of normal neonatal rats were as control group. The expression of PDGF-β was detected by western blot at 24 hours. Main outcome measures: Content of PDGF-β receptor in neonatal rat cardiac myocytes. Results: The expression of PDGF-β receptor induced by Ang II at neonatal rat cardiac myocytes markedly increased at 24 hours (432.41 ±54.08) compared with that of control group (197.65±44.10) (q=6.77, P < 0.01). PDGF-β receptor expression of PD98059 group(317.2±21.12) decreased compared with that of Ang II group(q=3.91, P < 0.05). However, the expression did not return to the level of control group, and there was significant difference between PD98059 group and control group(q =3.85, P < 0.05). Conclusion: The results indicate that angiotensin II promotes cardiac hypertrophy through inducing expression of PDGF receptor, in which mitogen activated protein kinase participates in. Maybe it is another important mechanism for Ang II-induced cardiac hypertrophy. The results can provide experimental data for the primary and secondary prevention in heart rehabilitation.

[Inhibition of Cardiac Hypertrophy by Mitofusin 2 in Neonatal Rat Cardiomyocytes].

Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.

Inhibition of Mitofusin-2 Promotes Cardiac Fibroblast Activation via the PERK/ATF4 Pathway and Reactive Oxygen Species

Abstract 3288: Mitofusin 2 Inhibits Cardiac Fibroblast Proliferation and Collagen Synthesis Stimulated by Angiotensin II in Rat

Translation of Myocyte Enhancer Factor-2 is Induced by Hypertrophic Stimuli in Cardiomyocytes Through a Calcineurin-dependent Pathway.

Abstract 298: Flavin Containing Monooxygenase 2 in Cardiac Fibrosis

MEF2C mediates inhibitory effect of microRNA-214 on cardiomyocyte hypertrophy

Attenuation of MicroRNA‐22 Derepressed PTEN to Effectively Protect Rat Cardiomyocytes from Hypertrophy

Restoration of Circulating MFGE8 (milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway

Mechanism of cardiac hypertrophy: Effect of mitogen activated protein kinase inhibitor on expression of platelet-derived growth factor receptor induced by angiotensin II in cardiac myocytes

Myocyte-specific Enhancer Factor 2C: a Novel Target Gene of Mir-214-3p in Suppressing Angiotensin II-induced Cardiomyocyte Hypertrophy.

Mitofusin-2 is a Major Determinant of Oxidative Stress-mediated Heart Muscle Cell Apoptosis

Role of PARP-2 selective inhibitor in cardiac hypertrophy in neonatal rat cardiomyocytes

lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

Alleviation of Angiotensin Ⅱ-induced Ventricular Hypertrophy in Neonatal Rat Cardiomyocytes by Endogenous Intermedin

Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.

Doxorubicin-induced Cardiomyocyte Apoptosis: Role of Mitofusin 2.

Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways.

Involvement of MLP in Cardiac Hypertrophy is Related to Calcineurin/NFAT Signaling Pathway

Mitofusin 2 Participates in Mitophagy and Mitochondrial Fusion Against Angiotensin II-Induced Cardiomyocyte Injury

Effect of Mitofusin 2 Gene with Protein Kinase A Phosphorylation Site Deletion on the Proliferation of Vascular Smooth Muscle Cells